Thomas Helmberger, MD, PhD, Muenchen Klinik Bogenhausen, München, Germany, discusses the interim analysis of the CIREL observational study, evaluating transarterial chemoembolisation (TACE) using irinotecan-eluting beads in patients with colorectal cancer (CRC) liver metastasis that are not eligible for curative treatment approaches. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).